Podcast TCTMD Talking Points COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting Listen to C. Michael Gibson in conversation with Giora Weisz.
Podcast TCTMD Talking Points PLATINUM DIVERSITY - Outcomes With Coronary Stenting in Women and Minorities C. Michael Gibson reviews new registry results with Wayne Batchelor.
Podcast TCTMD Talking Points Episode 30: PARTNER 2 Quality of Life C. Michael Gibson discusses health-status benefits in intermediate-risk patients treated with surgical or transcatheter aortic valve replacement.
Podcast TCTMD Talking Points Episode 29: ILLUMENATE US: A Paclitaxel-Coated Balloon vs an Uncoated Balloon for Diseased Superficial Femoral and Popliteal Arteries C. Michael Gibson sits down with Sean Lyden to discuss the results.
Podcast TCTMD Talking Points Episode 28: The AMULET Observational Study C. Michael Gibson speaks with David Hildick-Smith about left atrial appendage closure devices for stroke prevention.
Podcast TCTMD Talking Points Episode 27: The WATCHMAN US Postapproval Study C. Michael Gibson reviews the results with Vivek Reddy.
Podcast TCTMD Talking Points Episode 26: PARTNER 1 5-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After TAVR in High-Risk Aortic Stenosis C. Michael Gibson discusses the trial findings with Pamela Douglas.
Podcast TCTMD Talking Points Episode 25: RESPECT - Final Long-term Outcomes of PFO Closure for Cryptogenic Stroke C. Michael Gibson discusses the 10-year results with David Thaler.
Podcast TCTMD Talking Points Episode 24: BIONICS - Ridaforolimus-Eluting vs Zotarolimus-Eluting Stents in a More-Comers Population C. Michael Gibson talks with David Kandzari.
Podcast TCTMD Talking Points Episode 23: LEADERS FREE - Two-Year Clinical and Subgroup Outcomes C. Michael Gibson in conversation with Philip Urban.